Back
Skyline Champion Vs. Arcturus Therapeutics Holdings Industry Stock Comparison
Buy
72
SKY
Skyline Champion
Last Price:
82.00
Seasonality Move:
-0.74%
Sell
41
ARCT
Arcturus Therapeutics Holdings
Last Price:
24.11
Seasonality Move:
-0.89%
Buy
72
Skyline Champion (SKY)
is a Buy
Is Skyline Champion a Buy, Sell or Hold?
- The current Skyline Champion [SKY] share price is $77.56. The Score for SKY is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- SKY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?
- The current Arcturus Therapeutics Holdings [ARCT] share price is $22.98. The Score for ARCT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ARCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKY Stock Price Chart
What is Skyline Champion's stock price today?
-
The Skyline Champion share price today is $77.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SKY is experiencing slight selling pressure.
ARCT Stock Price Chart
What is Arcturus Therapeutics Holdings's stock price today?
-
The Arcturus Therapeutics Holdings share price today is $22.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SKY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.89 | Buy |
| Relative Strength Index (14 RSI): | 60.88 | Buy |
| Chaikin Money Flow: | -212298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.37 - 76.21) | Buy |
| Bollinger Bands (100): | (70.44 - 81.68) | Buy |
ARCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.32 | Sell |
| Relative Strength Index (14 RSI): | 42.03 | Sell |
| Chaikin Money Flow: | 267811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.11 - 25.51) | Sell |
| Bollinger Bands (100): | (24.67 - 35.33) | Sell |
SKY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.15 | Buy |
| 20-day SMA: | 72.24 | Buy |
| 50-day SMA: | 72.09 | Buy |
| 200-day SMA: | 71.97 | Buy |
| 8-day EMA: | 76.33 | Buy |
| 20-day EMA: | 74.01 | Buy |
| 50-day EMA: | 73.28 | Buy |
| 200-day EMA: | 72.46 | Buy |
ARCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.71 | Sell |
| 20-day SMA: | 23.16 | Sell |
| 50-day SMA: | 28.68 | Sell |
| 200-day SMA: | 29.29 | Sell |
| 8-day EMA: | 23.31 | Sell |
| 20-day EMA: | 24.19 | Sell |
| 50-day EMA: | 26.79 | Sell |
| 200-day EMA: | 29.03 | Sell |
Skyline Champion Earnings Growth & SKY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.15 per share, a decrease this year of $3.75 per share, and a decrease next year of $0.16 per share.
Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.08 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.63 per share, and an increase next year of $1.19 per share.
Skyline Champion Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arcturus Therapeutics Holdings Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||